The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives.
drug resistance
gastric cancer
helicobacter pylori
long non-coding RNA
tumor microenvironment
Journal
International journal of biological sciences
ISSN: 1449-2288
Titre abrégé: Int J Biol Sci
Pays: Australia
ID NLM: 101235568
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
04
2021
accepted:
08
06
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
18
3
2022
Statut:
epublish
Résumé
Gastric cancer (GC) is one of the major public health concerns. Long non-coding RNAs (lncRNAs) have been increasingly demonstrated to possess a strong correlation with GC and play a critical role in GC occurrence, progression, metastasis and drug resistance. Many studies have shed light on the understanding of the underlying mechanisms of lncRNAs in GC. In this review, we summarized the updated research about lncRNAs in GC, focusing on their roles in
Identifiants
pubmed: 34345204
doi: 10.7150/ijbs.61410
pii: ijbsv17p2737
pmc: PMC8326121
doi:
Substances chimiques
Biomarkers, Tumor
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2737-2755Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
J Pharmacol Exp Ther. 2006 Jan;316(1):271-8
pubmed: 16183703
Oncogene. 2018 Nov;37(45):5982-5996
pubmed: 29985481
Annu Rev Biochem. 2010;79:181-211
pubmed: 20192759
Cancer Chemother Pharmacol. 2016 May;77(5):1061-7
pubmed: 27056384
Annu Rev Immunol. 2012;30:531-64
pubmed: 22224781
Immunol Lett. 2018 Apr;196:74-79
pubmed: 29408410
Epigenomics. 2019 Aug;11(11):1307-1321
pubmed: 31368349
Cancer Manag Res. 2019 Jul 04;11:6175-6184
pubmed: 31308753
Onco Targets Ther. 2019 Oct 30;12:8841-8851
pubmed: 31802897
Clin Lab. 2019 Sep 1;65(9):
pubmed: 31532112
Clin Chim Acta. 2020 Feb;501:252-257
pubmed: 31730812
J Cancer. 2020 Apr 6;11(13):3882-3892
pubmed: 32328192
Mol Cancer. 2019 Jul 4;18(1):115
pubmed: 31272462
Am J Transl Res. 2018 Aug 15;10(8):2706-2711
pubmed: 30210707
Theranostics. 2017 Jan 1;7(1):213-227
pubmed: 28042329
Onco Targets Ther. 2019 Dec 20;12:11325-11338
pubmed: 31908497
Exp Mol Pathol. 2018 Feb;104(1):29-37
pubmed: 29273462
Biosci Biotechnol Biochem. 2018 Mar;82(3):456-465
pubmed: 29424266
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Mol Cancer. 2020 Mar 19;19(1):62
pubmed: 32192494
Int J Cancer. 2011 Jun 1;128(11):2527-35
pubmed: 21365651
Biochem Biophys Res Commun. 2019 Feb 12;509(3):753-762
pubmed: 30638658
J Immunol. 1999 Aug 1;163(3):1128-31
pubmed: 10415006
Acta Pharm Sin B. 2019 Mar;9(2):203-219
pubmed: 30972274
Cancer Res. 2019 Jun 1;79(11):2821-2838
pubmed: 30952633
J Cell Biochem. 2018 Mar;119(3):2787-2796
pubmed: 29053187
Front Immunol. 2019 Aug 29;10:1942
pubmed: 31555258
Mol Cancer. 2016 Oct 27;15(1):67
pubmed: 27784305
World J Gastroenterol. 2019 May 7;25(17):2029-2044
pubmed: 31114131
J Cell Biochem. 2020 Feb;121(2):1353-1361
pubmed: 31478258
Mol Cancer. 2020 May 27;19(1):96
pubmed: 32460771
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2794-2802
pubmed: 31002130
BMC Cancer. 2014 Dec 11;14:932
pubmed: 25496320
Tumour Biol. 2016 Nov 30;:
pubmed: 27900563
Pathog Dis. 2019 Dec 1;77(9):
pubmed: 31981356
Aging (Albany NY). 2018 Dec 29;10(12):4294
pubmed: 30594911
Nat Commun. 2017 May 25;8:15129
pubmed: 28541302
Int Immunopharmacol. 2020 Oct;87:106845
pubmed: 32763781
Biomed Pharmacother. 2020 May;125:109961
pubmed: 32028241
Cancer Med. 2019 Nov;8(15):6768-6779
pubmed: 31517442
Biomed Pharmacother. 2018 Nov;107:185-193
pubmed: 30089248
Cell Rep. 2017 Jul 18;20(3):558-571
pubmed: 28723561
Oncogene. 2018 May;37(20):2660-2675
pubmed: 29483646
Genes Cancer. 2018 Mar;9(3-4):87-100
pubmed: 30108680
J Clin Lab Anal. 2019 Oct;33(8):e22962
pubmed: 31273847
Mol Cancer. 2020 Jul 29;19(1):118
pubmed: 32727463
Mol Cancer. 2017 Nov 21;16(1):174
pubmed: 29162158
Cell Death Dis. 2020 Jan 27;11(1):64
pubmed: 31988283
Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3199-205
pubmed: 27466992
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14944-9
pubmed: 21896770
Int J Biol Macromol. 2018 Oct 15;118(Pt A):24-30
pubmed: 29886172
Cancer Manag Res. 2019 Sep 20;11:8589-8602
pubmed: 31572012
Cell Rep. 2015 Jun 23;11(11):1703-13
pubmed: 26074077
Cancer Control. 2020 Jan-Dec;27(1):1073274820904694
pubmed: 32019330
J Cancer. 2019 Jan 29;10(4):1013-1022
pubmed: 30854107
Cell Rep. 2016 May 31;15(9):2000-11
pubmed: 27210762
J Cancer Res Clin Oncol. 2016 Jul;142(7):1571-9
pubmed: 27095450
J Hematol Oncol. 2019 Jul 5;12(1):71
pubmed: 31277692
Cell Mol Biol Lett. 2020 Apr 25;25:29
pubmed: 32351584
Mol Med Rep. 2018 Oct;18(4):4009-4015
pubmed: 30132541
Pathol Oncol Res. 2018 Jan;24(1):109-113
pubmed: 28401449
J Cell Mol Med. 2019 Jan;23(1):656-669
pubmed: 30338929
Cancer Cell. 2014 May 12;25(5):605-20
pubmed: 24823638
Int J Clin Exp Pathol. 2014 Dec 01;7(12):8471-9
pubmed: 25674211
Oncotarget. 2016 Aug 30;7(35):56209-56218
pubmed: 27486823
Gastric Cancer. 2019 Jul;22(4):692-704
pubmed: 30560474
J Exp Med. 2017 Sep 4;214(9):2695-2713
pubmed: 28739604
Am J Transl Res. 2016 Nov 15;8(11):5035-5043
pubmed: 27904704
J Inflamm (Lond). 2019 Nov 26;16:23
pubmed: 31787851
Oncotarget. 2016 Aug 9;7(32):51763-51772
pubmed: 27322075
Cancer Discov. 2016 Jul;6(7):784-801
pubmed: 27147598
Med Sci Monit. 2016 Oct 01;22:3506-3513
pubmed: 27694794
Mol Cancer. 2018 Feb 27;17(1):68
pubmed: 29486794
Nat Rev Cancer. 2018 Jan;18(1):5-18
pubmed: 29170536
ACS Chem Biol. 2016 Feb 19;11(2):308-18
pubmed: 26730496
Oncogene. 2018 Aug;37(34):4723-4734
pubmed: 29760406
Gastric Cancer. 2019 Jul;22(4):731-741
pubmed: 30603909
Oncogene. 2017 Oct 12;36(41):5661-5667
pubmed: 28604750
Oncol Lett. 2018 Sep;16(3):3706-3714
pubmed: 30127981
Oncotarget. 2017 Feb 28;8(9):15393-15398
pubmed: 28146436
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020 Apr 28;42(2):228-235
pubmed: 32385030
J Cell Biochem. 2020 Jan;121(1):557-565
pubmed: 31338903
Mol Ther Nucleic Acids. 2018 Sep 7;12:405-419
pubmed: 30195778
Oncogene. 2017 May 25;36(21):3048-3058
pubmed: 27991933
Biochem Biophys Res Commun. 2015 Sep 18;465(2):225-31
pubmed: 26248136
Theranostics. 2020 Jul 11;10(19):8880-8902
pubmed: 32754285
Semin Cancer Biol. 2019 Dec;59:1-2
pubmed: 31689493
J Exp Clin Cancer Res. 2017 Dec 28;36(1):194
pubmed: 29282102
PLoS Pathog. 2010 Jul 29;6(7):e1001026
pubmed: 20686662
Biochem Biophys Res Commun. 2017 Mar 11;484(3):514-521
pubmed: 28115163
J Hematol Oncol. 2015 Jul 10;8:83
pubmed: 26156517
J Cancer Res Clin Oncol. 2017 Jun;143(6):991-1004
pubmed: 28285404
Asian Pac J Cancer Prev. 2014;15(15):6295-300
pubmed: 25124614
Aging (Albany NY). 2020 Jun 9;12(11):11025-11041
pubmed: 32516127
Cancers (Basel). 2018 Jan 19;10(1):
pubmed: 29351204
Biomed Pharmacother. 2019 Oct;118:109255
pubmed: 31352238
Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7653-7659
pubmed: 30536307
Helicobacter. 2015 Sep;20 Suppl 1:30-5
pubmed: 26372822
Mol Cell Biol. 2014 Sep;34(17):3182-93
pubmed: 24958102
Biosci Rep. 2019 May 17;39(5):
pubmed: 31028131
Cell Physiol Biochem. 2017;42(3):999-1012
pubmed: 28683446
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8852-8860
pubmed: 31696472
FASEB J. 2013 Jan;27(1):3-12
pubmed: 23012321
Biosci Rep. 2019 Apr 5;39(4):
pubmed: 30886062
PLoS Pathog. 2014 Apr 03;10(4):e1004030
pubmed: 24699527
Oncogene. 2018 Jul;37(30):4094-4109
pubmed: 29706652
J Med Biochem. 2016 Apr;35(2):137-143
pubmed: 28356873
Biochem Biophys Res Commun. 2015 Jul 3;462(3):227-32
pubmed: 25956062
Life Sci. 2020 Mar 1;244:117280
pubmed: 31926239
Nat Immunol. 2007 Dec;8(12):1353-62
pubmed: 17982458
Cancer Biol Med. 2018 Aug;15(3):238-250
pubmed: 30197791
Cell Physiol Biochem. 2018;51(3):1221-1236
pubmed: 30481766
Mol Ther Nucleic Acids. 2020 Mar 6;19:109-123
pubmed: 31837602
Nat Med. 2016 Jun;22(6):679-84
pubmed: 27111280
Mol Cell Biochem. 2019 Jun;456(1-2):73-83
pubmed: 30635820
Microb Pathog. 2020 Dec;149:104442
pubmed: 32795593
BMC Med Genomics. 2015 Dec 21;8:84
pubmed: 26690385
Jpn J Infect Dis. 2015;68(1):63-6
pubmed: 25420666
J Clin Invest. 2020 Jul 1;130(7):3901-3918
pubmed: 32538894
Ther Adv Med Oncol. 2019 Sep 24;11:1758835919874651
pubmed: 31579114
J Exp Clin Cancer Res. 2015 Nov 04;34:135
pubmed: 26538117
Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4064-4070
pubmed: 29028095
Oncol Rep. 2016 Jul;36(1):263-70
pubmed: 27121324
Oncol Rep. 2020 Feb;43(2):718-726
pubmed: 31894346
Cell Oncol (Dordr). 2020 Oct;43(5):863-876
pubmed: 32729021
Anticancer Res. 2020 May;40(5):2645-2655
pubmed: 32366409
Oncotarget. 2016 Dec 13;7(50):82770-82782
pubmed: 27835575
Front Genet. 2020 Aug 11;11:715
pubmed: 32849774
J Recept Signal Transduct Res. 2015;35(6):600-4
pubmed: 26096166
J Cell Biochem. 2018 Sep;119(9):7226-7234
pubmed: 29856087
Oncogene. 2019 Jun;38(23):4637-4654
pubmed: 30742067
Cancer Biol Ther. 2020;21(1):17-25
pubmed: 31591939
Exp Biol Med (Maywood). 2019 Sep;244(12):953-959
pubmed: 31242038
Sci Rep. 2015 Jun 22;5:11516
pubmed: 26096073
Mol Cancer. 2018 Jan 12;17(1):6
pubmed: 29329543
Onco Targets Ther. 2020 May 12;13:4049-4061
pubmed: 32494159
Mol Cancer. 2019 Mar 30;18(1):64
pubmed: 30927925
Open Biol. 2019 Sep 27;9(9):190068
pubmed: 31551012
Gastric Cancer. 2021 Jan;24(1):45-59
pubmed: 32572790
RNA Biol. 2020 Nov;17(11):1576-1589
pubmed: 31885317
Mol Cancer. 2018 Apr 24;17(1):84
pubmed: 29690888
Brief Bioinform. 2019 Jul 19;20(4):1492-1501
pubmed: 29579224
Cell Cycle. 2015;14(19):3112-23
pubmed: 26237576
Am J Transl Res. 2015 Nov 15;7(11):2262-9
pubmed: 26807174
Biomed Pharmacother. 2020 Feb;122:109726
pubmed: 31918283
Oncotarget. 2016 Apr 12;7(15):20549-60
pubmed: 26942879